ReviewAntioxidants (Basel, Switzerland)2025

SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk.

Silvia Fernanda López Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.